News

Why Investing in REITs Could Be a Smart Move in 2025

Why Investing in REITs Could Be a Smart Move in 2025

REITs Are Set for a Rebound

Real estate investment trusts (REITs) are beginning to show signs of recovery from a significant slowdown experienced during the pandemic. The current market presents an exciting opportunity to invest at attractive price points, potentially allowing investors to capitalize on rising dividend yields that are starting to emerge.

Rather than investing directly in REITs, many are looking towards REIT-focused closed-end funds (CEFs) which offer dividend yields of 7% or higher. This strategic shift could yield significant benefits as the market evolves.

REIT Performance vs. the S&P 500

Comparatively, while the S&P 500 has thrived over the past five years with a remarkable annualized return of 14.0%, REITs have only managed a modest return of 2.6% during the same timeframe. This stark contrast is unusual, as historically, REITs tend to outperform the broader stock market. The SPDR Dow Jones REIT ETF (NYSE:RWR) highlights this disparity, representing a concerning trend for investors.

Understanding REITs and Home Prices

The recent decline in REIT performance is particularly surprising given that there has not been a considerable shift in the relationship between REIT prices and housing market trends. In previous economic cycles, gains in housing markets often translated into increased demand and prices for REIT shares. However, present trends show REIT prices faltering despite rising housing values, leading to a disconnection between asset valuations.

The Effect of Current Market Conditions

Housing prices have exhibited a consistent annual growth of 7.2% over the last decade, while REITs have only managed a 3.7% increase. This discrepancy is raising questions about the sustainability of such growth in housing prices. With high mortgage rates pressing down on affordability, it seems reasonable to expect some level of correction in the housing market.

This underperformance in REITs may indicate that a lot of the negative outlook has already been factored into current prices, presenting a valuable buying opportunity for investors. The relationship between home values and REIT prices historically indicates a potential for recovery and growth.

Future Prospects for REITs

Looking ahead, it is expected that interest rates will decline, whether sooner or later. Such a change would enhance affordability for home buyers and subsequently drive demand for real estate rental properties, indirectly benefiting REITs. As interest rates fall, the cost of borrowing will also decrease, allowing REITs to finance property acquisitions more efficiently.

This increased leverage can significantly boost REIT profits, with more income translating into higher dividends for investors. With the right investments, REITs are primarily positioned for substantial growth. There’s evidence they are already increasing borrowing, enabling further expansions and enhancing their net asset values in the near future.

Growing Dividends in the REIT Market

Despite facing challenges, many REITs have managed to raise payouts to their shareholders, achieving an increase of 7.5% since pre-pandemic levels. This shift reflects a growing focus on delivering value to investors, making them an attractive consideration for anyone looking for consistent income.

Certain sectors, such as data centers and infrastructure, are thriving, indicating robust demand which is likely to support REIT growth regardless of the broader interest rate trends. As the work culture shifts back to in-office environments, office REITs are also projected to recover, driven by corporate strategies aimed at returning workers to office spaces.

Choosing Between CEFs and ETFs

Given the current climate, the REIT's yield—such as that from RWR—is relatively low and may not meet all investor goals. A more strategic approach could involve investing in a closed-end fund like the Cohen & Steers (NYSE:CNS) Quality Income Realty Fund (NYSE:RQI), which boasts an impressive sustained yield of around 8% over the last nine years.

Positioning in The Market

RQI has outperformed peers, trading at a discount which could potentially rebound into a premium as demand for yields grows. With substantial diversification into sectors demonstrating resilience—such as telecommunications and healthcare—RQI appears well equipped for future growth.

Given these insights, the future of REITs looks promising, and their ability to adapt and thrive will determine long-term investor gains.

Frequently Asked Questions

1. What are REITs?

REITs, or Real Estate Investment Trusts, are companies that own, operate, or finance income-generating real estate. They allow individuals to invest in large-scale real estate portfolios.

2. How do REITs generate income?

REITs primarily generate income through leasing space and collecting rents on the properties they own.

3. Why are REITs performing poorly compared to the S&P 500?

REITs have faced a downturn possibly due to changing market conditions and rising interest rates that have affected real estate investment sentiment.

4. What benefits do closed-end funds offer compared to ETFs?

Closed-end funds can offer higher yields and often trade at discounts to their net asset value, providing unique opportunities for investors.

5. How can I invest in REITs effectively?

Investing in REITs can be done through direct purchases of shares or through mutual funds or closed-end funds that focus on REITs, optimizing potential returns based on market conditions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

CeraVe Marks 20 Years of Groundbreaking Skincare Innovations

Updated Category News Views 259

CeraVe's Celebrated Journey in Skincare CeraVe is making waves as it marks an impressive milestone: 20 years of dedicated skincare science. Launching with the mission to nurture and restore skin health, the brand has garnered an extensive following of both customers and dermatology professionals worldwide. By focusing on skin barrier health and utilizing innovative...

Continue Reading
Exploring Novartis' Latest Innovations in Hematology and Oncology

Updated Category News Views 320

Novartis Pioneers Innovations in Hematology and Oncology Basel – Novartis has been making headlines with groundbreaking data presented at major medical meetings, including the esteemed American Society of Hematology (ASH) Annual Meeting and the San Antonio Breast Cancer Symposium (SABCS). This year, Novartis is showcasing over 70 abstracts with significant findings that...

Continue Reading
Sustainable Green Team Reveals Patents for Eco-Innovation

Updated Category News Views 189

Innovative Patents by Sustainable Green Team Sustainable Green Team, Ltd. (OTC: SGTM) is making significant strides in environmental responsibility by filing an impressive portfolio of 20 U.S. provisional patent applications. This initiative marks the unveiling of the SGTM 20-Patent Fortress™, consolidating the company's dedication to revolutionizing waste management...

Continue Reading
SSL's C2PA Game Changer: Authenticity or Just Hype?

Updated Category News Views 172

SSL just dropped a bombshell on the digital content authenticity scene. On February 18, 2026, they announced themselves as the first publicly trusted certificate authority to roll out production-ready C2PA-conformant certificates. But what’s behind all this noise? Desks are buzzing about whether this marks a real breakthrough against deepfakes and misinformation or if...

Continue Reading
MiMedia's Innovations at Mobile World Congress Excite Investors

Updated Category News Views 95

MiMedia Partners with Orbic at Mobile World Congress MiMedia Holdings Ltd. is excited to announce its collaboration with Orbic, a prominent US OEM, to develop and market the new line of rugged devices under the Caterpillar brand. This partnership was highlighted during the recently attended Mobile World Congress conference, where innovative trends within the tech industry...

Continue Reading